Welcome to our dedicated page for Guardian Pharmacy Services SEC filings (Ticker: GRDN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
It’s one thing to appreciate how Guardian Pharmacy Services, Inc. keeps assisted-living residents adherent to medication; it’s another to untangle the reimbursement footnotes, controlled-substance disclosures, and state-by-state regulations buried in SEC reports. Investors routinely spend hours locating pharmacy automation costs or Medicaid mix details, which is why searches like “Guardian Pharmacy Services insider trading Form 4 transactions” or “how to read the company’s 10-K” are so common.
Stock Titan’s AI solves that complexity. Our platform delivers Guardian Pharmacy Services quarterly earnings report 10-Q filing highlights, with segment revenue and technology spend distilled into plain language. Need governance data? The Guardian Pharmacy Services proxy statement executive compensation tables are cross-referenced against prior years. Real-time alerts surface Guardian Pharmacy Services Form 4 insider transactions real-time, so you never miss executive stock transactions Form 4. Sudden news is covered through Guardian Pharmacy Services 8-K material events explained, while bigger-picture trends appear in the Guardian Pharmacy Services annual report 10-K simplified. Every document streams from EDGAR the moment it’s posted, complete with AI-powered summaries that make Guardian Pharmacy Services SEC filings explained simply.
Whether you’re tracking margin pressures, comparing quarter-over-quarter adherence metrics, or timing trades around board activity, understanding Guardian Pharmacy Services SEC documents with AI saves hours. Dive into Guardian Pharmacy Services earnings report filing analysis, export numbers directly to your model, or monitor compliance flags—all in one place. From insider activity to cash-flow shifts, our comprehensive coverage equips professionals to act decisively.
Wellington Management group disclosed beneficial ownership of 1,107,657 shares of Guardian Pharmacy Services, Inc. common stock, representing approximately 4.88% (reported also as 4.9%) of the class. The reporting entities hold no sole voting or dispositive power and report shared voting power on 815,159 shares and shared dispositive power for the full 1,107,657 shares.
The filing states these securities are owned of record by clients of Wellington Investment Advisers and were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
Guardian Pharmacy Services, Inc. reported second-quarter 2025 revenue of $344.3 million (up 14.8% year-over-year) and year-to-date revenue of $673.6 million (up 17.1%). The company served about 195,000 residents across 52 pharmacies and dispensed 7.0 million prescriptions in the quarter, driving organic and acquisition-backed growth.
Quarterly net income was $8.8 million (six-month net income $18.1 million), below the prior-year comparable periods of $15.8 million and $22.9 million, respectively. Cost of goods sold increased as a percentage of revenue to 80.2% in Q2 2025, and selling, general and administrative expense rose to $55.6 million (16.1% of revenue), driven by higher headcount and share-based compensation. Adjusted EBITDA improved to $48.4 million for the six months ended June 30, 2025 (from $41.9 million).
The company completed an IPO and a follow-on offering that generated net proceeds of $119.8 million from the IPO and used proceeds from the follow-on to repurchase and cancel 1,440,447 Class A shares. Cash and cash equivalents increased to $18.8 million. Management completed multiple acquisitions (2025 preliminary purchase consideration of $11.1 million with $6.9 million of goodwill recorded).
ClearBridge Investments, LLC filed Amendment No. 2 to Schedule 13G reporting its ownership of Guardian Pharmacy Services, Inc. (GRDN) Class A common stock as of 30 June 2025. The institutional investor, organized in Delaware and classified as an investment adviser (IA), disclosed beneficial ownership of 445,524 shares, representing approximately 2.0 % of the outstanding class.
ClearBridge has sole voting power over 403,089 shares and sole dispositive power over the full 445,524-share position; it reports no shared voting or dispositive power. Because the holding is below the 5 % threshold, the filing notes “Ownership of 5 percent or less of a class.” The securities are held in the ordinary course for multiple managed accounts, and ClearBridge disclaims beneficial ownership beyond its investment-management authority. The certification affirms no intent to influence control of the issuer. Signature is provided by Chief Compliance Officer Brian R. Murphy on 5 Aug 2025.
On 06/30/2025 The Vanguard Group filed Amendment No. 1 to Schedule 13G covering Guardian Pharmacy Services Inc. (GRDN). Vanguard reports beneficial ownership of 966,806 common shares (CUSIP 40145W101), equal to 4.25 % of the outstanding stock. The investment adviser holds 0 shares with sole voting power and 16,335 shares with shared voting power; it retains 934,250 shares with sole dispositive power and 32,556 shares with shared dispositive power. Vanguard certifies the stake is held in the ordinary course of business with no intent to influence control. Item 5 notes that ownership is now below the 5 % reporting threshold.
FAQ
What is the current stock price of Guardian Pharmacy Services (GRDN)?
What is the market cap of Guardian Pharmacy Services (GRDN)?
